Iovance Biotherapeutics

7 followers

Iovance Biotherapeutics (NASDAQ: IOVA) aims to improve patient care for people living with cancer. Iovance is investigating T cell-based therapies, known as tumor infiltrating lymphocytes (TIL), which use a patient’s own immune cells to attack cancer.

Industries

Employees

201-500

Links


Org chart

Interim CEO and General Counsel
Collapse
COO
Chief Business Officer
SVP, Head of Digital & Information Technology
EVP, Human Resources
EVP, Quality
SVP, Research
Executive Counsel
Executive Counsel
Chief Commercial Officer (cco)
Svp, Investor Relations & Corporate Communications
Senior Patent Counsel
Associate General Counsel
Executive Director
Senior Securities And Corporate Counsel
Executive Counsel, Litigation & Dispute Resolution

Board & advisors

Chairman
Director
Director
Director
Director
Director